Profile for Australia Patent: 2015228962
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Australia Patent: 2015228962
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Sep 10, 2033 | Salix | PLENVU | ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate |
| ⤷ Start Trial | Sep 10, 2033 | Salix | PLENVU | ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate |
| ⤷ Start Trial | Sep 10, 2033 | Salix | PLENVU | ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate |
| ⤷ Start Trial | Sep 10, 2033 | Salix | PLENVU | ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate |
| ⤷ Start Trial | Sep 10, 2033 | Salix | PLENVU | ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
